FRI-2K.201-HP-05
HOMOCYSTEINЕ: METABOLIC, CLINICAL AND IATROGENIC INTERACTIONS
Abstract
This cross-sectional observational study investigates the clinical, metabolic, and iatrogenic determinants of serum homocysteine in general outpatient practice. A total of 52 sex-balanced patients (26 males and 26 females) with confirmed normal serum folate and vitamin B6 levels and no dietary restrictions were included. Biochemical parameters, comorbidities, pharmacotherapy, and lifestyle factors were evaluated using comparative and correlational statistical analyses. Results indicate that baseline demographic factors such as sex (𝑝 = 0.672) and age (𝑝 = 0.956), as well as isolated cardiovascular diseases (𝑝 = 0.971), lipid fractions, and HbA1c, do not independently influence homocysteine levels. Conversely, chronic proton pump inhibitor (PPI) therapy emerged as the primary determinant of marked hyperhomocysteinemia (17.56 ± 2.58 vs. 10.80 ± 3.59 µmol/L; 𝑝 < 0.001, Cohen’s 𝑑 = 1.919), accompanied by a significant decline in vitamin B12 status (𝑝 = 0.004). Metformin therapy was also associated with a significant reduction in cobalamin levels (𝑝 = 0.045). The relationship with vitamin B12 exhibited a distinct threshold effect (ANOVA, 𝑝 = 0.002). Serum creatinine correlated positively with homocysteine (𝜌 = 0.297,𝑝 = 0.033), reflecting renal elimination dynamics, while alcohol consumption proved to be a significant behavioral modifier (𝑝 = 0.014). Smoking, caffeine, and physical activity did not reach statistical significance. In conclusion, in outpatient primary care, homocysteine functions primarily as a functional marker of iatrogenically induced malabsorption and subclinical organ dysfunction rather than an isolated cardiovascular predictor, highlighting the necessity of targeted laboratory monitoring during long-term PPI and metformin therapy.
Keywords
Homocysteine, Vitamin B12, Proton Pump Inhibitors, Metformin, Serum Creatinine, General Medical Practice
REFERENCES
- Angelova, E.A., Minkova, G.D., Atanasova, P.A., Semerdjieva, M.A. and Tzvetkova, T.Z. (2005) 'A study of plasma total homocysteine levels in healthy people', Folia Med (Plovdiv), 47(3-4), pp. 53-58.
- Angelova, E.A., Minkova, G.D. and Tsvetkova, T.Z. (2006) 'Total plasma homocysteine in Bulgarian population measured by high-performance liquid chromatography with fluorescence detection- comparison with fluorescence polarization immunoassay', Clin Lab, 52(9-10), pp. 527-533.
- Cleveland Clinic Laboratories (2021) Homocysteine: Clinical Guidelines, Diagnostic Algorithm and Metabolic Pathways. Cleveland (OH): Cleveland Clinic.
- de Bree, A., Verschuren, W.M., Blom, H.J. and Kromhout, D. (2001) 'Lifestyle factors and plasma homocysteine concentrations in a general population sample', Am J Epidemiol, 154(2), pp. 150-157.
- Ducros, V., Belva-Besnet, H., Casetta, B. and Favier, A. (2002) 'A robust liquid chromatography- tandem mass spectrometry method for total homocysteine determination in plasma', Clinica Chimica Acta, 323(1-2), pp. 101-109.
- Finkelstein, J.D. (1990) 'Methionine metabolism in mammals', The Journal of Nutritional Biochemistry, 1(5), pp. 228-237.
- Frantzen, F., Faaren, A.L., Alfheim, I. and Nordhei, A.K. (1998) 'An enzyme conversion immunoassay for determining total homocysteine in plasma or serum', Clinical Chemistry, 44(2), pp. 311-316.
- Majchrzak, D., Singer, I., Männer, M., Rust, P., Genser, D. and Wagner, K.H. (2006) 'B-vitamin status and total homocysteine in vegans and omnivores', Ann Nutr Metab, 50(6), pp. 485-491.
- Mudd, S.H., Levy, H.L. and Kraus, J.P. (2001) 'Disorders of transsulfuration', in The Metabolic and Molecular Bases of Inherited Disease, 8, pp. 2007-2056.
- Nygård, O., Refsum, H., Ueland, P.M. and Vollset, S.E. (1997) 'Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study', Am J Clin Nutr, 65(1), pp. 136-143.
- Popova, I., Lozanov, V. and Miteva, L. (2016) 'Homocysteine and Comorbidity in Psoriasis - Interrelationships and Correlations', GP News, (10), pp. 15-18.
- Refsum, H., Ueland, P.M., Nygård, O. and Vollset, S.E. (1998) 'Homocysteine and cardiovascular disease', Annual Review of Medicine, 49(1), pp. 31-62.
- Refsum, H., Smith, A.D., Ueland, P.M., Nexo, E., Clarke, R., McPartlin, J. and Scott, J.M. (2004) 'Facts and recommendations about total homocysteine determinations: an expert opinion', Clinical Chemistry, 50(1), pp. 3-32.
- Selhub, J. (1999) 'Homocysteine metabolism', Annual Review of Nutrition, 19(1), pp. 217-246.
- Tan, Y., Tang, L., Sun, X., Zhang, N., Han, Q., Xu, M. and Hoffman, R.M. (2000) 'Enzymatic assay for total homocysteine in circulating blood', Clinical Chemistry, 46(10), pp. 1686-1688.
- The HOPE-2 Investigators (2006) 'Homocysteine lowering with folic acid and B vitamins in vascular disease', N Engl J Med, 354(15), pp. 1567-1577.
- The SEARCH Collaborative Group (2010) 'Effects of homocysteine-lowering with folic acid plus vitamin B12 in patients with previous myocardial infarction (SEARCH): a randomised, placebo-controlled trial', Lancet, 376(9748), pp. 1233-1244.
- The VITATOPS Trial Study Group (2010) 'B vitamins in patients with recent transient ischaemic attack or ischaemic stroke (VITATOPS trial): a randomised, double-blind, parallel, placebo-controlled trial', Lancet Neurol, 9(9), pp. 855-865.
- Toole, J.F., Malinow, M.R., Chambless, L.E., Spence, J.D., Pettigrew, L.C., Howard, V.J. et al. (2004) 'Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial', JAMA, 291(5), pp. 565-575.
- Trancheva, D. (2023) 'Homocysteine-predictor of pathological changes in the human body', Proc Univ Ruse, 62(Ser 8.4), pp. 11-15.
- Ueland, P.M., Refsum, H., Stabler, S.P., Green, R., Nygård, O. and Allen, R.H. (1993) 'Total homocysteine in plasma or serum: methods and clinical applications', Clinical Chemistry, 39(9), pp. 1764- 1779.
- van Guldener, C. and Stehouwer, C.D. (2003) 'Homocysteine metabolism in renal disease', Clinical Chemistry and Laboratory Medicine, 41(11), pp. 1412-1417.
- Weiss, N., Heydrick, S.J., Postea, O., Keller, P., Keaney, J.F. and Loscalzo, J. (2003) 'Influence of hyperhomocysteinemia on the cellular redox state-impact on endothelial dysfunction', Clin Chem Lab Med, 41(11), pp. 1455-1461.